Paknikar / Gajbhiye | Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics | Buch | 978-0-12-816963-6 | sack.de

Buch, Englisch, 432 Seiten, Format (B × H): 235 mm x 193 mm, Gewicht: 998 g

Paknikar / Gajbhiye

Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics


Erscheinungsjahr 2019
ISBN: 978-0-12-816963-6
Verlag: Elsevier Science Publishing Co Inc

Buch, Englisch, 432 Seiten, Format (B × H): 235 mm x 193 mm, Gewicht: 998 g

ISBN: 978-0-12-816963-6
Verlag: Elsevier Science Publishing Co Inc


Polymeric Nanoparticles as Promising Tool for Anti-cancer Therapeutics provides an understanding of polymeric compounds and their use in cancer therapies. The book begins by giving an overview of the current status, future challenges and potential utilization of polymeric nanoparticles. It then covers specific polymeric nanoparticles through contributions from world-renowned experts and researchers. Chapters examine specific polymeric nanoparticles, their development as potential targeted delivery systems, and cancer characteristics that can be targeted for therapy development. The book synthesizes current research trends in the field, thus enhancing existing knowledge of nanomedicine, drug delivery and therapeutic intervention strategies in human cancers.

Users will find this to be an ideal reference for research scientists and those in the pharmaceutical and medical fields who are working to develop novel cancer therapies using nanoparticle-based delivery systems.

Paknikar / Gajbhiye Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics jetzt bestellen!

Zielgruppe


Research scientists and industry professionals in pharmaceutical science, biomedicine, polymer science, nanomedicine, cancer research and biotechnology who are working on technological advancement in designing targeted therapies and drug delivery systems

Weitere Infos & Material


1. Current status and future challenges of various polymers as cancer therapeutics2. An overview of polymeric nanoparticles as potential cancer therapeutics3. Poly acrylate (e.g., poly methylacrylate, poly ethyl acrylate, etc.) nanoparticles as promising tool for anticancer therapeutics4. Poly (alkyl cyano acrylate) nanoparticles as promising tool for anticancer therapeutics5. Poly (?-hydroxy acids) based nanoparticles for Drug/Gene delivery for cancer therapy6. Poly (ester), Poly hydroxy alkanoate nanoparticles as promising tool for anticancer therapeutics7. Poly (phospho ester), Poly (phosphazene) nanoparticles as promising tool for anticancer therapeutics8. Poly (carbonate) nanoparticles as promising tool for anticancer therapeutics9. Poly (amino acid) nanoparticles as promising tool for anticancer therapeutics10. Poly ethylene glycol nanoparticles as promising tool for anticancer therapeutics11. Dendrimer (polyamidoamine, polypropylene imine, poly-L-lysine, carbosilane dendrimers, triazine dendrimers) as promising tool for anticancer therapeutics12. Conjugated polymer nanoparticles as promising tool for anticancer therapeutics13. Microbes based natural polymer (Xanthum gum, alginate, gellan gum, carrageenan) nanoparticles as promising tool for anticancer therapeutics14. Plant based natural polymer (Guar gum, pectin, starch, cellulose, cyclodextrins) nanoparticles as promising tool for anticancer therapeutics15. Animal based natural polymer (Gelatin, chitosan, albumin, hyaluronic acid, chondroitin sulphate) nanoparticles as promising tool for anticancer therapeutics16. Polymersomes as promising tool for anticancer therapeutics17. Other polymers (Poly sulfonic acids, Poly carboxylic acids, Poly boronic acid, Poly silamine, etc.) nanoparticles as promising tool for anticancer therapeutics18. Conclusion and future prospective of polymeric nanoparticles as cancer therapeutics


Gajbhiye, Virendra
Dr. Virendra Gajbhiye has been working in the field of nanomedicine for the last 15 years. He has a doctoral degree (Ph.D.) in Pharmaceutical Science with post-doctoral research experience at University of Wisconsin-Madison and Oregon Health and Sciences University. Since 2013 he is working as a Scientist in Nanomedicine at Agharkar Research Institute, Pune, India. He has worked extensively with polymeric nanoparticles specially dendrimers and mesoporous silica nanoparticles. His research interest lies in Nanomedicine, Targeted drug and siRNA delivery, Biomedical application of dendrimers, Biomaterials unimolecular micelles and imaging, Multifunctional polymeric nanoparticles, Nanoparticles in tissue engineering.

Paknikar, Kishore M.
Dr. Kishore M. Paknikar is Professor Agharkar Chair and former Director of Agharkar Research Institute, Pune, India. He is a MSc in Microbiology (1980) and a PhD in Microbiology (1984) from the University of Poona, India. His work in the field of delivery systems focuses on the delivery of drugs, proteins, peptides, siRNA, and nutrients. He is also exploring systems like polymeric nanoparticles and dendrimers for delivery of bioactive molecules in the treatment of cancers, Alzheimer's disease, candidiasis, etc. He has more than 120 publications in highly reputed journals and 33 patents to his credit. He was a visiting Professor at Louis Pasteur University (Strasbourg, France) and Wayne State University (School of Medicine, Detroit, USA). He also worked as a Research Advisor at National Nanotechnology Centre (Ministry of Science and Technology), Bangkok, Thailand. He has several fellowships and awards to his credit.



Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.